Orthostatic hypotension is also called postural hypotension. It
occurs when a patient’s blood pressure decreases while standing up
or sitting down. Orthostatic hypotension can be defined as fall in
systolic blood pressure by at least 20mm Hg or fall in diastolic
blood pressure by at least 10mm Hg while standing up or lying down.
Postural hypotension can make a person feel light headed, dizzy, and
even faint. Orthostatic hypotension is caused due to various reasons
such as dehydration, heart problems, endocrine problems, and nervous
systems disorders. The person suffering from this disorder can be at
risk of fainting, stroke, or cardiovascular diseases.
The global orthostatic hypotension market is expect to expand at a
significant CAGR during the forecast period. Orthostatic hypotension
is considered one of the common cardiovascular diseases, underlying
neurodegenerative disorders. According to the Journal of the American
College of Cardiology, prevalence of orthostatic hypotension is
between 5% and 30%, globally. This is one key factor driving the
global orthostatic hypotension market. Rise in geriatric population
and unhealthy lifestyle such as alcoholism are attributed to the
growth of the global market. Furthermore, prevalence of certain
chronic diseases such as diabetes, medication such as antipsychotics,
and relaxants that increase the risk of orthostatic hypotension are
factors likely to propel the global market during the forecast
period. Side effects of the treatment and lack of awareness among the
people toward the disorder in developing countries are factors
restraining the global orthostatic hypotension market.
The global orthostatic hypotension market can be segmented based on
drug class, diagnostic test, end-user, and region. In terms of drug
class, the global orthostatic hypotension market can be divided
Fludrocortisone, midodrine, indomethacin, NSAIDs, oxilofrine, and
others. Based on diagnostic test, the global market can be
categorized into blood tests, stress tests, ECG, and others. In terms
of end-user, the global orthostatic market can be segmented into
hospitals, clinics, ambulatory surgical centers, and others. The
hospitals segment is expected to register significant growth due to
increase in number of hospitals and health care expenditure.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31322
Geographically, the global orthostatic hypotension market can be
segmented into North America, Latin America, Europe, Asia Pacific,
and Middle East & Africa. North America is anticipated to
dominate the market, accounting for the largest share. Increase in
prevalence of obesity in young adults and children leading to
orthostatic hypotension is one of the major factors driving the
market in the region. Furthermore, advanced technology, rise in
awareness among people toward diagnosis of the disorders, high health
care expenditure, and availability of the drugs are some of the
factors attributed to the growth of the orthostatic hypotension
market in North America. Europe is also anticipated to account for a
significant share of the global market. Factors attributed to the
growth of the market in the region are increase in geriatric
population and rise in health care expenditure. The market in Asia
Pacific is anticipated to register faster growth rate during the
forecast period. Asia Pacific is the most lucrative market due to
rising geriatric population, adoption of health care solutions for
better standard of life, rise in awareness about health, prevalence
of lifestyle related diseases, and high investment in health care
sector.
Key players in the global orthostatic hypotension market have adopted
strategies such as mergers, acquisitions, cost effective and
efficient drugs, and collaborative partnerships to gain leadership
position. Major players operating in the global orthostatic
hypotension market are H. Lundbeck A/S, Amgen, Inc., Shire plc, and
Hoffmann-La Roche Limited, among others.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=31322<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment